BETHESDA — Non-alcoholic fatty liver disease (NAFLD) is an emerging problem related to the obesity epidemic, becoming one of the most common causes of liver disease in the nation. A recent study published in Clinical Gastroenterology and Hepatology, an official journal of the American Gastroenterological Association (AGA) Institute, reports bariatric surgery results in improvement of histopathological features of NAFLD.
Complications of NAFLD, including steatosis, steatohepatitis and fibrosis appeared to improve or completely resolve in a majority of patients after bariatric surgery-induced weight loss, according to results of the study.
“Even today, the effect of weight loss after bariatric surgery on the liver, particularly NAFLD, remains unclear. There is a lack of well-defined trials exploring this relationship,” said Gagan K. Sood, MD, of the University of Texas Medical Branch and lead author of the study. “Our team assessed and quantified this effect and found encouraging news—a majority of patients experience complete resolution of NAFLD after bariatric surgery, and the risk of progression of inflammatory changes and fibrosis seems to be minimal.”
For this meta-analysis, 15 studies were selected for final data extraction. The mean age of the participants at the time of weight loss surgery ranged from 35.6 to 49 years. Mean BMI at the time of weight-loss surgery ranged from 43.9 to 56 kg/m2 and the mean BMI at follow-up liver biopsies ranged from 28.6 to 39kg/m2. Percentage reduction in mean BMI values ranged from 19.11 to 41.76.
